Quotazione viking therapeutics
WebInstitutional Ownership and Shareholders. Viking Therapeutics Inc (US:VKTX) has 187 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,729,604 shares. Largest shareholders include Vanguard Group Inc, Millennium Management Llc, Balyasny ... WebApr 11, 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 8 buy ratings for VKTX. …
Quotazione viking therapeutics
Did you know?
WebMar 30, 2024 · Viking Therapeutics stock was originally listed at a price of $8.96 in Apr 29, 2015. If you had invested in Viking Therapeutics stock at $8.96, your return over the last 7 … WebApr 13, 2024 · The Viking Therapeutics stock price gained 1.56% on the last trading day (Monday, 10th Apr 2024), rising from $16.68 to $16.94. During the last trading day the …
WebApr 13, 2024 · Toute l'actualité sur VIKING THERAPEUTICS, INC. 04/04. Vente d'initié : Viking Therapeutics. MT. 03/04. Viking Therapeutics clôture l'offre publique d'actions ordinaires. MT. 30/03. Viking ... WebViking Therapeutics Inc () Stock Market info Recommendations: Buy or sell Viking Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Viking Therapeutics's VKTX shares and potentially its …
WebJul-29-21 08:02PM. Viking Therapeutics (VKTX) Q2 2024 Earnings Call Transcript. Motley Fool. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype ... WebALERT Click here to register with a few steps and explore all our cool stuff we have to offer!
WebWhy Shares of Viking Therapeutics Skyrocketed This Week. Shares of Viking Therapeutics (NASDAQ: VKTX) were up 89.7% for the week as of Thursday afternoon, after being up as …
WebFind the latest analyst research for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. people born on jan 1 1998WebStock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. people born on jan 12thWebApr 11, 2024 · 8 Wall Street research analysts have issued twelve-month target prices for Viking Therapeutics' shares. Their VKTX share price forecasts range from $15.00 to … toeic 411WebGet the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … toeic 411問WebMar 17, 2024 · Analisi Viking Therapeutics VKTX : Il commento dell'Esperto. Analisi tecnica dettagliata, andamento nel tempo, resistenza, analisi fondamentale, prezzo, volume e … people born on jan 14thWebApr 14, 2024 · Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CEO Brian Lian sold 79,336 shares of the stock in a transaction dated Thursday, April 13th.The shares were sold at an average price of $18.45, for a total value of $1,463,749.20. Following the completion of the sale, the chief executive officer now directly owns 2,307,963 shares in the company, … toeic 410点WebViking Therapeutics Prices 17.24M Share Offering at $14.50/sh. By Investing.com - 8h ago. Viking Therapeutics (NASDAQ:VKTX), Inc. (Nasdaq: VKTX), a clinical-stage … toeic410点